Michael S. Hwang

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Targeting a neoantigen derived from a common TP53 mutation”.

Targeting a neoantigen derived from a common TP53 mutation

Science(2021)10.1126/science.abc8697

N/A

0.880DataRank · unranked

351 citations

Katharine M. Wright, Jacqueline Douglass, Michael S. Hwang, Brian J. Mog, Alexander H. Pearlman +20 more

Peripheral blood immune cell dynamics reflect antitumor immune responses and predict clinical response to immunotherapy

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-004688

N/A

0.743DataRank · unranked

141 citations

Jenna VanLiere Canzoniero, Samuel Rosner, Guangfan Zhang, James R. White, Zineb Belcaid +22 more

Targeting loss of heterozygosity for cancer-specific immunotherapy

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2022410118

N/A

0.652DataRank · unranked

76 citations

Brian J. Mog, Jacqueline Douglass, Alexander H. Pearlman, Emily Han-Chung Hsiue, Suman Paul +10 more

TCR β chain–directed bispecific antibodies for the treatment of T cell cancers

Science Translational Medicine(2021)10.1126/scitranslmed.abd3595

N/A

0.612DataRank · unranked

58 citations

Alexander H. Pearlman, Jacqueline Douglass, Brian J. Mog, Emily Han-Chung Hsiue, Michael S. Hwang +15 more

TRBC1-targeting antibody–drug conjugates for the treatment of T cell cancers

Nature(2024)10.1038/s41586-024-07233-2

N/A

0.574DataRank · unranked

45 citations

Jiaxin Ge, Brian J. Mog, Bum Seok Lee, Alexander H. Pearlman, Michael S. Hwang +22 more

Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens

Nature Communications(2021)10.1038/s41467-021-25605-4

N/A

0.553DataRank · unranked

39 citations

Michelle S. Miller, Puchong Thirawatananond, Jacqueline Douglass, Katharine M. Wright, Emily Han-Chung Hsiue +17 more

Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen

Nature Communications(2023)10.1038/s41467-023-40821-w

N/A

0.489DataRank · unranked

25 citations

Sarah R. DiNapoli, Michelle S. Miller, P. Aitana Azurmendi, Xiaowei Zhao, Zhiheng Yu +17 more

Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities

Science Translational Medicine(2024)10.1126/scitranslmed.adg7123

N/A

0.489DataRank · unranked

25 citations

Nikita Marcou, Sarah R. DiNapoli, Alexander H. Pearlman, Tushar D. Nichakawade, Michael S. Hwang +19 more

Engineering immunotoxin-equipped effector cells and evaluation in primary human immune cells

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.64898/2025.12.09.691975

N/A

0.104DataRank · unranked

1 citations

Brian J. Mog, Michael S. Hwang, Jordina Rincón-Torroella, Sarah R. DiNapoli, Suman Paul +11 more